SCHEMBL28660616

SCHEMBL28660616

N#Cc1ccc2c(c1)CCN2C(O)CSc1nnnn1-c1ccc(C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.46
▸ MEN1 O00255 7/20 0.44
▸ KMT2A Q03164 7/20 0.44
▸ ALDH1A1 P00352 7/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ PPARG P37231 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ TP53 P04637 1/20 0.39
▸ POLB P06746 4/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ ATM Q13315 1/20 0.38
▸ ALPL P05186 3/20 0.38
▸ ALPG P10696 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28673832 0.88 MEN1 (0.53) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28669727 0.88 MEN1 (0.48) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28659024 0.88 ALDH1A1 (0.48) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28664789 0.85 HPGD (0.45) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28655707 0.85 ALDH1A1 (0.51) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL21952032 0.82 TSHR (0.63) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL21952036 0.77 TSHR (0.42) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28678930 0.75 HPGD (0.50) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL21952064 0.73 MAPT (0.60) HPGDMEN1KMT2AALDH1A1MAPK1
SCHEMBL28676728 0.73 HPGD (0.53) HPGDMEN1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
CN-113677340-A Compounds that selectively and efficiently inhibit Hakai-mediated ubiquitination as anti-cancer agents 诺沃亚桑托斯教授基金会 2021-11-19 — — CN disclosed
Send feedback